Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria
- PMID: 2413146
- DOI: 10.1093/infdis/152.5.954
Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria
Abstract
Antiserum to rough gram-negative mutants such as Escherichia coli J5 and Salmonella minnesota Re595 is thought to neutralize the toxic effects of lipopolysaccharides (LPSs). To verify that such antisera are capable of binding heterologous endotoxins, we examined IgG and IgM class antibodies induced in rabbits to a variety of LPSs. Immunization with rough mutants or lipid A induced high IgG antibody responses to the homologous purified LPS and relatively low but significant responses to heterologous LPSs. Increases in IgM antibodies were also primarily to homologous LPS. Immunization with smooth organisms induced little or no antibody to heterologous LPSs. Soluble LPS, outer membrane vesicles, and whole bacteria produced strong homologous inhibition but little or no heterologous inhibition in enzyme-linked immunosorbent assays. Cross-adsorption of antisera to rough mutants suggested that the IgG and IgM antibodies induced to heterologous LPS were adsorbed by the heterologous LPS and not by the core LPS used to immunize the animals. Rabbit antibody directed to J5 or Re595 LPS fails to bind to any substantial degree to heterologous LPS. Immunization with whole bacterial vaccines, particularly the rough mutants and lipid A, does increase antibody to a wide variety of antigens. The possibilities that the protective effects of antisera to rough mutants are due to a polyclonal antibody response or to the induction of as yet unidentified factor(s) deserve further investigation.
Similar articles
-
Endotoxin neutralization with rabbit antisera to Escherichia coli J5 and other gram-negative bacteria.Infect Immun. 1987 Jul;55(7):1668-73. doi: 10.1128/iai.55.7.1668-1673.1987. Infect Immun. 1987. PMID: 3298063 Free PMC article.
-
Cross-reactivity of monoclonal antibodies to Escherichia coli J5 with heterologous gram-negative bacteria and extracted lipopolysaccharides.J Infect Dis. 1989 Nov;160(5):846-57. doi: 10.1093/infdis/160.5.846. J Infect Dis. 1989. PMID: 2681436
-
Demonstration of cross-reactive antibodies to smooth gram-negative bacteria in antiserum to Escherichia coli J5.J Infect Dis. 1987 Jul;156(1):136-43. doi: 10.1093/infdis/156.1.136. J Infect Dis. 1987. PMID: 2439613
-
Reactivity of antibodies to core glycolipid with gram-negative bacteria.Rev Infect Dis. 1987 Sep-Oct;9 Suppl 5:S639-43. doi: 10.1093/clinids/9.supplement_5.s639. Rev Infect Dis. 1987. PMID: 2446371 Review.
-
Cross-reactive antigens: their potential for immunization-induced immunity to Gram-negative bacteria.J Infect Dis. 1977 Aug;136 Suppl:S161-6. doi: 10.1093/infdis/136.supplement.s161. J Infect Dis. 1977. PMID: 330775 Review.
Cited by
-
[Lipopolysaccharides, endotoxins and O-antigens of gram-negative bacteria: chemical structure, biologic effect and serologic properties].Infection. 1987 Mar-Apr;15(2):133-41. doi: 10.1007/BF01650219. Infection. 1987. PMID: 2439461 German. No abstract available.
-
Longitudinal study of antibody response to lipopolysaccharides during chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.Infect Immun. 1988 Sep;56(9):2270-8. doi: 10.1128/iai.56.9.2270-2278.1988. Infect Immun. 1988. PMID: 3410536 Free PMC article.
-
Murine monoclonal antibodies to Klebsiella pneumoniae protect against lethal endotoxemia and experimental infection with capsulated K. pneumoniae.Infect Immun. 1990 Sep;58(9):2828-33. doi: 10.1128/iai.58.9.2828-2833.1990. Infect Immun. 1990. PMID: 1696932 Free PMC article.
-
Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides.Infection. 1991 Nov-Dec;19(6):383-90. doi: 10.1007/BF01726444. Infection. 1991. PMID: 1816107 Review. No abstract available.
-
Perspectives on the potential for successful development of outer membrane protein vaccines.Eur J Clin Microbiol. 1987 Jun;6(3):231-3. doi: 10.1007/BF02017606. Eur J Clin Microbiol. 1987. PMID: 3305003 Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources